Navigation Links
Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
Date:1/24/2011

fluoroquinolones), older age (over 65) and exposure to emerging hyper-virulent strains (BI/NAP1/027, 078, 001) of C. difficile. The increasing incidence of CDI, along with higher rates of both treatment failures and recurrences with current therapies have resulted in greater awareness and concern about CDI among medical professionals and public health officials. You may learn more about CDI at www.cdiinfo.org, a website of Optimer.

About FidaxomicinFidaxomicin is the first in a new class of antibiotics called macrocycles, which inhibit the bacterial enzyme RNA polymerase, resulting in the rapid killing of C. difficile. The narrow-spectrum profile of fidaxomicin eradicates C. difficile selectively with minimal disruption to the normal intestinal flora, while the alternative antibiotics used to treat CDI, metronidazole and vancomycin, have been shown to disrupt the gut flora. Fidaxomicin facilitates the return of normal physiological conditions in the colon which may be responsible for reducing CDI recurrence rates. Optimer has filed applications in the U.S. and the EU for marketing authorization for fidaxomicin for the treatment of CDI and reducing risk of recurrence when used for treatment of initial CDI.

About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ (prulifloxacin).  Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).  The Company has submitted an NDA to the FDA, and filed a MAA with the European Medicines Agency (EMA) for fidaxomicin. Pruvel™ is a prodrug in the fluoroquinolone class of antibiotics being deve
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  El Camino Hospital, a leader in the use ... Leaf Patient Monitoring system to help prevent hospital-acquired pressure ... susceptible to bed sores. The decision was ... the system, which showed dramatic improvement in compliance with ... the one of the most effect ways to prevent ...
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... SANTA CLARA, Calif. , July 30, 2014 /PRNewswire/ ... innovation economy, released a study today that ... venture-backed biopharma and medical device companies.  According to the ... healthcare saw the biggest potential returns since SVB started ... the year of the IPO.  Built on solid healthcare ...
Breaking Medicine Technology:El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3
...  IRIDEX Corporation (Nasdaq: IRIX ) announced ... of IRIDEX, MicroPulse laser therapy.  The study examined ... central serous chorioretinopathy (CSC).(1) The study concluded tissue-sparing ... for CSC, also known as CSR, an eye ...
... Texas, Jan. 25, 2012 UNT Health Science Center ... Myron (Mike) Jacobson, Ph.D., as the founding dean of ... search we were very pleased to recruit a renowned ... academic leader in pharmacy education, and a successful entrepreneur ...
Cached Medicine Technology:IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC) 2IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC) 3UNT System Names Jacobson Founding Dean of College of Pharmacy 2UNT System Names Jacobson Founding Dean of College of Pharmacy 3
(Date:7/31/2014)... 2014 FORT LAUDERDALE, FLORIDA – ... leading US Joint Commission Accredited teleradiology and telemedicine ... technologically advanced consumer storage and sharing platform for ... providing valued members the use of its Cloud-based ... already offered by SecondOpinions.com®. , Wide-spread radiologic ...
(Date:7/31/2014)... Lauderale, FL (PRWEB) July 31, 2014 ... accepting referrals of insurance patients seeking massage therapy in ... company provides an option for Licensed Massage Therapists who ... refer these patients to BWT. Should a patient request ... the referral, BWT can then contract the therapist to ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 What’s ... practice provider? Community Health Center of Snohomish answers ... Pediatricians vs. Family Doctors ”. Many adults can ... available to them. Community Health Center hopes to ... and differences between the two. , To ...
(Date:7/31/2014)... When it comes to aesthetics and wellness, ... As such, Natalie Sharp's Pure Vitality Rx ... new, more focused direction and to provide the latest ... Pure Vitality Rx is Oyster Bay's premier aesthetic, anti-aging ... of services primarily dedicated to women. Services include injectables ...
(Date:7/31/2014)... Some pain relief medications can be as ... Every day, 46 people in the U.S. die from ... people are admitted to an emergency room because of opioid ... the dangers of prescription and over-the-counter painkillers and is calling ... more to make these drugs safer. , The full report, ...
Breaking Medicine News(10 mins):Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 2Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 3Health News:Community Health Center of Snohomish County Reveals the Differences Between Pediatricians and Family Practice Providers 2Health News:Natalie Sharp's Pure Vitality Rx Upgrade - Partnership With Shangri-La Spa and Website Facelift! 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 3
... , FARMINGDALE, N.Y., Sept. 2 Misonix, ... invasive ultrasonic medical device technology, which in Europe is used ... health conditions, today announced the restructuring and expansion of its ... created; one for sales and service of the Sonablate(R) 500 ...
... Fox Chase Cancer Center has received an $8 million ... the National Institutes of Health (NCRR/NIH) to expand their ... will support advanced research into the fundamental biological processes ... new treatments. The funds for the grant were made ...
... the total mortality rate from unintentional injury increased in the ... increases were seen in some subgroups analyzed by age, race, ... Hopkins Bloomberg School of Public Health,s Center for Injury Research ... and 64 years old experienced a 230 percent increase in ...
... - Researchers are developing computer models to comb through ... or insurance claims data to automatically classify them based ... to identify the most important causes of injuries so ... of injuries in society," said Mark Lehto, an associate ...
... Washington Post study, approximately 20% of U.S. soldiers returning ... are a substantial number with post-traumatic stress disorder (PTSD), ... has become unacceptable to Army commanders and the soldiers, ... University, however, doctors will now be able to forecast ...
... ... , ... -- Spend one hour with Delaine Anderson, and it,s clear she does not shrink from life,s ... in different parts of the country before that. She even lived seven years in Greece, where ...
Cached Medicine News:Health News:Misonix Restructures and Expands Sales Organization in Europe 2Health News:Misonix Restructures and Expands Sales Organization in Europe 3Health News:Misonix Restructures and Expands Sales Organization in Europe 4Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2Health News:Deaths from unintentional injuries increase for many groups 2Health News:New computer models aim to classify, help reduce injury accidents 2Health News:Keeping the suicidal soldier alive 2Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 2Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 3Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 4
... single-use instruments on the market., Available in standard ... Surgery. , Dual action tips provide maximum ... points to reduce the chance of alternative burn ... eliminates gapping at connection and the need for ...
Disposable sheath for use with 5mm AEM Laparoscopic Instruments ....
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: